DRGEM Corporation (263690) - Total Liabilities
Based on the latest financial reports, DRGEM Corporation (263690) has total liabilities worth ₩34.12 Billion KRW (≈ $23.12 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
DRGEM Corporation - Total Liabilities Trend (2015–2025)
This chart illustrates how DRGEM Corporation's total liabilities have evolved over time, based on quarterly financial data. See DRGEM Corporation short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
DRGEM Corporation Competitors by Total Liabilities
The table below lists competitors of DRGEM Corporation ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Tevogen Bio Holdings Inc.
NASDAQ:TVGN
|
USA | $14.76 Million |
|
Swiss Properties Invest A/S
CO:SWISS
|
Denmark | Dkr454.08 Million |
|
Brand Group (M.G) Ltd
TA:BRND
|
Israel | ILA615.29 Million |
|
Lantern Pharma Inc
NASDAQ:LTRN
|
USA | $4.04 Million |
|
Kyung Chang Industrial Co. Ltd
KQ:024910
|
Korea | ₩360.97 Billion |
|
LOOP INDUSTRIES DL-001
F:3L9
|
Germany | €18.61 Million |
|
BG Staffing Inc
NYSE:BGSF
|
USA | $32.89 Million |
|
The Beachbody Company, Inc.
NASDAQ:BODI
|
USA | $108.78 Million |
Liability Composition Analysis (2015–2025)
This chart breaks down DRGEM Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see DRGEM Corporation market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.20 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.36 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.27 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how DRGEM Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for DRGEM Corporation (2015–2025)
The table below shows the annual total liabilities of DRGEM Corporation from 2015 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₩29.85 Billion ≈ $20.23 Million |
-15.56% |
| 2024-12-31 | ₩35.36 Billion ≈ $23.96 Million |
-27.98% |
| 2023-12-31 | ₩49.09 Billion ≈ $33.27 Million |
-7.50% |
| 2022-12-31 | ₩53.07 Billion ≈ $35.97 Million |
+130.34% |
| 2021-12-31 | ₩23.04 Billion ≈ $15.61 Million |
+14.63% |
| 2020-12-31 | ₩20.10 Billion ≈ $13.62 Million |
-34.15% |
| 2019-12-31 | ₩30.52 Billion ≈ $20.69 Million |
+73.36% |
| 2018-12-31 | ₩17.61 Billion ≈ $11.93 Million |
-6.12% |
| 2017-12-31 | ₩18.75 Billion ≈ $12.71 Million |
+2.58% |
| 2016-12-31 | ₩18.28 Billion ≈ $12.39 Million |
+17.14% |
| 2015-12-31 | ₩15.61 Billion ≈ $10.58 Million |
-- |
About DRGEM Corporation
DRGEM Corporation manufactures and sells diagnostic radiography systems. It offers high frequency X-ray generators; conventional and digital radiography systems; and ACQUIDR, a digital imaging system. DRGEM Corporation exports its products. The company was founded in 2003 and is headquartered in Gwangmyeong-si, South Korea.